AllianceBernstein’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-863
Closed -$102K 3291
2022
Q1
$102K Sell
863
-267
-24% -$43.5K ﹤0.01% 3115
2021
Q4
$241K Hold
1,130
﹤0.01% 3011
2021
Q3
$373K Hold
1,130
﹤0.01% 2876
2021
Q2
$294K Buy
1,130
+270
+31% +$167K ﹤0.01% 3013
2021
Q1
$392K Sell
860
-290
-25% -$158K ﹤0.01% 2781
2020
Q4
$402K Sell
1,150
-157
-12% -$61.9K ﹤0.01% 2694
2020
Q3
$500K Hold
1,307
﹤0.01% 2531
2020
Q2
$585K Hold
1,307
﹤0.01% 2503
2020
Q1
$452K Buy
1,307
+307
+31% +$112K ﹤0.01% 2404
2019
Q4
$275K Hold
1,000
﹤0.01% 2810
2019
Q3
$268K Sell
1,000
-10
-1% -$2.34K ﹤0.01% 2843
2019
Q2
$254K Buy
+1,010
New +$183K ﹤0.01% 2883

Other funds holding CVM

AllianceBernstein's CVM Position: Q2 2022 in Review

AllianceBernstein sold out of CEL-SCI Corp (CVM) in Q2 2022, closing a stake of 863 shares — an estimated $102K sold.

AllianceBernstein first reported a position in CVM in Q2 2019 and held it in 12 quarters. The position peaked at $585K in Q2 2020. 81 funds tracked by Wall St. Rank hold CVM as of Q2 2022.

  • AllianceBernstein reported no remaining CEL-SCI Corp position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 863 CEL-SCI Corp shares in Q2 2022, an estimated $102K.
  • AllianceBernstein first reported a position in CEL-SCI Corp in Q2 2019 and held it in 12 quarters.
  • AllianceBernstein's CEL-SCI Corp position peaked at $585K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.